What I'm Watching With Goldman Sachs to See if It Beats the Market

Goldman Sachs derives ~19% of revenue from investment banking (Q4 investment banking revenue $2.58B) versus Morgan Stanley $2.41B (13% of rev) and JPMorgan $2.55B (5.5% of rev), underpinning its recent outperformance (stock +53% in 2025; 3-yr annualized ~39%). M&A activity is off to a record Q1 in 2026, with 2025 deal value up 43% vs. 2024, driven by lower rates, pent-up demand and AI-driven acquisitions — a strong tailwind for Goldman. Trading at ~15x earnings and with Q1 results due April 13, upside to the stock from better-than-expected investment banking results could move the shares in the near term.

Analysis

Goldman’s business mix makes it a directional play on the M&A cycle rather than a pure bank spread story; when deal flow accelerates you get a levered uplift across advisory fees, underwriting, and ancillary financing products (syndications, bridge loans, equity capital markets). That lever creates asymmetric return potential versus universal banks that have larger, steadier deposit and consumer franchises — those peers will protect earnings in a drawdown but won’t capture upside as cleanly if the deal wave continues.

Second-order beneficiaries include leveraged loan and high-yield primary desks, law firms and specialized due-diligence boutiques, and equity derivatives desks that monetize volatility around deal announcements. Conversely, regional banks and smaller IB boutiques risk margin compression as large houses win trophy mandates that bundle follow-on financing and trading flow. AI-driven strategic buying changes buyer composition (tech acquirers, PE with enterprise software targets), which lengthens deal diligence and increases demand for cross-product syndication (underwriting + financing + hedging).

Key risks are a snap-back in the rate path, a macro slowdown that stalls strategic capex, and regulatory or antitrust scrutiny of large tech deals — any of these would flip the IB beta negative quickly. Timescales matter: earnings and booking windows can move stock prices in days, but a true re‑rating requires months of sustained fee capture. The consensus upside assumes continued deal momentum; the contrarian case is that this is a cyclical top concentrated in a few large mandates and will mean-revert, so position sizing and convexity management are critical.

Key Decisions for Investors

• Pair trade: Go long GS (1–2% portfolio) and short JPM (equal dollar) for 3–6 months to isolate M&A/advisory exposure. Rationale: isolates advisory beta versus deposit/treasury businesses; size as a tactical trade and trim if cross-product revenue underperforms. Stop-loss: 6–8% on net position.
• Options hedge: Buy a 3–6 month GS call spread (buy near-the-money, sell 20–25% OTM) sized to 0.75–1% portfolio to capture upside while capping premium; fund with sale of 1–2% OTM puts if comfortable with assignment. Target 2.5–3x asymmetric upside vs max premium risk.
• Tactical long NVDA (0.5–1% portfolio, 6–12 months) to play increased AI-driven strategic M&A demand; if wary of single-stock volatility, use a 9–12 month call spread. Risk: regulatory/valuation compression in AI names; reward: acquisition-led re-rating for AI incumbents.
• Credit trade: Reduce exposure to floating-rate leveraged loan ETFs and instead buy short-dated investment-grade bank debt/ETFs if you want defensive carry for 3–9 months. Rationale: preserves yield if M&A stalls and investor risk appetite falls; downside limited versus holding leveraged-credit-sensitive instruments.